Skip to main content
Log in

Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project

  • Cardiovascular disease
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

There is little epidemiological data on heart failure (HF) in the younger age groups dominating clinical HF trials. We assessed gender-specific long-term HF incidence and mortality in an urban community-based sample of middle-aged subjects. Between 1974 and 1992, 33,342 HF-free subjects (10,900 [32.7%] women, mean age 45.7 ± 7.4 years) were included in the Malmö Preventive Project, on average 21.7 ± 4.3 years before study end. Patients hospitalised for or dying of HF were categorised as HF patients, and 120 (1.1%) women versus 644 (2.9%) men experienced HF: 6.0 vs. 12.3 cases per 10,000 person years; hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.50–0.74, P < 0.0001. Among all subjects, women compared with men had lower all-cause (49.3 vs. 84.0 cases per 10,000 person years; HR 0.68, 95% CI 0.64–0.73, P < 0.0001) and HF-related (2.6 vs. 7.4 cases per 10,000 person years; HR 0.50, 95% CI 0.37–0.67, P < 0.0001) mortality risk. Female and male HF patients had similar age-adjusted mortality risk: 1,314 vs. 1,602 cases per 10,000 patient years; HR 0.78, 95% CI 0.58–1.07, P = 0.12. Among HF patients, 55.3% of deaths in women and 40.6% in men were non-cardiovascular, and only 7.9% deaths were due to HF. In conclusion: In a middle-aged, urban, community-based sample, women had lower risk of HF, all-cause death and HF-related death over two decades of follow-up. Female and male HF patients had similar mortality risk after the diagnosis of HF. In these comparatively young HF patients, few deaths were due to HF and more than 4 out of 10 deaths were non -cardiovascular.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schocken DD, Arrietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–6.

    PubMed  CAS  Google Scholar 

  2. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women’s hearts. Circulation. 1999;99:2334–41.

    PubMed  CAS  Google Scholar 

  3. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22:6A–13A.

    PubMed  CAS  Google Scholar 

  4. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121:951–7. doi:10.1016/0002-8703(91)90225-7.

    Article  PubMed  CAS  Google Scholar 

  5. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJV, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–33. doi:10.1016/S0140-6736(97)03033-X.

    Article  PubMed  CAS  Google Scholar 

  6. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–62. doi:10.1001/jama.275.20.1557.

    Article  PubMed  CAS  Google Scholar 

  7. Galderisi M, Andersson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham heart study). Am J Cardiol. 1991;68:85–9. doi:10.1016/0002-9149(91)90716-X.

    Article  PubMed  CAS  Google Scholar 

  8. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study. Circulation. 1993;88:107–15.

    PubMed  CAS  Google Scholar 

  9. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure, Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001;103:375–80.

    PubMed  CAS  Google Scholar 

  10. Lenzen MJ, Rosengren A, Scholte op Reimer WJS, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10–78. doi:10.1136/hrt.2006.099523.

    Article  PubMed  CAS  Google Scholar 

  11. Jessup M, Pina IL. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure. J Thorac Cardiovasc Surg. 2004;127:1247–52. doi:10.1016/j.jtcvs.2003.09.032.

    Article  PubMed  Google Scholar 

  12. Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsson BY. Health-related quality of life in elderly patients with heart failure. Scand Cardiovasc J. 1999;33:278–85. doi:10.1080/14017439950141524.

    Article  PubMed  CAS  Google Scholar 

  13. Strömberg A, Mårtensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003;2:7–8. doi:10.1016/S1474-5151(03)00002-1.

    Article  PubMed  Google Scholar 

  14. SOLVD The investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med. 1992;327:685–91.

    Article  Google Scholar 

  15. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35.

    Google Scholar 

  16. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992;327:669–77.

    PubMed  CAS  Google Scholar 

  17. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312–8.

    PubMed  CAS  Google Scholar 

  18. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–55. doi:10.1056/NEJM199605233342101.

    Article  PubMed  CAS  Google Scholar 

  19. MERIT-HF StudyGroup. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001–7. doi:10.1016/S0140-6736(99)04440-2.

    Article  Google Scholar 

  20. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–8. doi:10.1056/NEJM200105313442201.

    Article  PubMed  CAS  Google Scholar 

  21. Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amplodipine on morbidity and mortality in severe heart failure. N Engl J Med. 1996;335:1107–14. doi:10.1056/NEJM199610103351504.

    Article  PubMed  CAS  Google Scholar 

  22. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–33. doi:10.1056/NEJM199702203360801.

    Article  Google Scholar 

  23. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–7. doi:10.1016/S0140-6736(00)02213-3.

    Article  PubMed  CAS  Google Scholar 

  24. Feinglass J, Martin GJ, Lin E, Johnson MR, Gheorghiade M. Is heart failure survival improving? Evidence from 2323 elderly patients hospitalized between 1989–2000. Am Heart J. 2003;146:111–4. doi:10.1016/S0002-8703(03)00116-9.

    Article  PubMed  Google Scholar 

  25. Gustafsson F, Torp-Pedersen C, Burchart H, Buch P, Seibaek M, Kjoller E, et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J. 2004;25:129–35. doi:10.1016/j.ehj.2003.10.003.

    Article  PubMed  Google Scholar 

  26. Mejhert M, Holmgren J, Wandell P, Persson H, Edner M. Diagnostic tests, treatment, and follow-up in heart failure patients—is there a gender bias in the coherence to guidelines. Eur J Heart Fail. 1999;1:407–10. doi:10.1016/S1388-9842(99)00053-7.

    Article  PubMed  CAS  Google Scholar 

  27. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, et al. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247:19–29. doi:10.1046/j.1365-2796.2000.00568.x.

    Article  PubMed  CAS  Google Scholar 

  28. European Society of Cardiology, Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the diagnosis and treatment of Chronic Heart Failure. Eur Heart J. 2001;22:1527–60. doi:10.1053/euhj.2001.2783.

    Article  PubMed  CAS  Google Scholar 

  29. Tasevska-Dinevska G, Kennedy LM, Anevski D, Nilsson P, Christensson A, Willenheimer R. Gender differences in predictors of heart failure morbidity and mortality in an urban Swedish population: the Malmö preventive project. Open Heart Fail J. 2008;1:1–8. doi:10.2174/1876535100801010001.

    Article  Google Scholar 

  30. Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787–91. doi:10.1016/j.ejheart.2004.12.007.

    Article  PubMed  Google Scholar 

  31. Deswal A, Bozkurt B. Comparasion of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006;97:1228–31. doi:10.1016/j.amjcard.2005.11.042.

    Article  PubMed  Google Scholar 

  32. Fraizer CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction. A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007;49:1450–8. doi:10.1016/j.jacc.2006.11.041.

    Article  Google Scholar 

  33. Willenheimer R. Statistical significance versus clinical relevance in cardiovascular medicine. Prog Cardiovasc Dis. 2001;44:155–67. doi:10.1053/pcad.2001.29144.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We want to express our gratitude to all staff for assistance in this study and all subjects who participated in tis study.

Conflict of Interest

None in relation to the presented work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Tasevska-Dinevska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tasevska-Dinevska, G., Kennedy, L.M.A., Nilsson, P.M. et al. Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project. Eur J Epidemiol 24, 249–257 (2009). https://doi.org/10.1007/s10654-009-9320-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-009-9320-4

Keywords

Navigation